Iron Supplementation in Non-Anemic Pregnancy and Risk of Developing Gestational Diabetes Mellitus

Preeyaporn Jirakittidul, Supatra Sirichotiyakul, Chidchanok Ruengorn, Siwaporn Siripenpong, Arinporn Imruetaicharoenchok, Busaba Wiriyasirivaj

Abstract


Background: Routine iron supplementation for all pregnant women in order to reduce adverse neonatal outcomes has been a standard practice in developing countries, including Thailand. However, there is evidence that excess iron can affect glucose metabolism and may increase risk of gestational diabetes mellitus (GDM). This study aims to investigate the association of iron supplementation starting from early gestation and the risk of GDM in non-anemic women.

Methods: This retrospective cohort study included non-anemic pregnant Thai women who received their first antenatal care and delivered at Vajira Hospital (Bangkok, Thailand) during January 2008 to December 2009. All pregnant women underwent oral glucose tolerance test during gestational weeks 24 - 28. The proportions of ongoing GDM and birth outcomes were compared between the early oral iron supplementation group (before 16 completed weeks) and the control group (after 16 weeks).

Results: There were 1,935 non-anemic pregnant women, 966 in the early supplement group and 969 in the control group. The early supplement group had significantly higher prevalence of GDM than the control group did (9.7% vs. 5.6%, RR: 1.83; 95% CI: 1.29 - 2.59). No significant differences in maternal anemia, gestational age at birth, or neonatal birth weight were observed between groups.

Conclusions: Early antenatal iron supplementation in non-anemic pregnant women was found to be associated with significantly increased risk of GDM.




J Endocrinol Metab. 2018;8(6):139-143
doi: https://doi.org/10.14740/jem543

 


Keywords


Iron supplementation; Non-anemic pregnancy; Gestational diabetes mellitus; Thai

Full Text: HTML PDF
 
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe


 

     

Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board

Archives

Copyright

Company Profile

Editorial Office

Misconduct and Retraction

Permissions

Company Registration

Contact Us

Abstracting and Indexing

ICMJE

Ownership

Instructions to Authors

Access

Declaration of Helsinki

Contact Publisher

Submission Checklist

Reprints

Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy

Disclaimer

Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians

Careers

Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal

       
       

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.        
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.